临床微生物学档案

  • 国际标准期刊号: 1989-8436
  • 期刊 h 指数: 22
  • 期刊引用分数: 7.55
  • 期刊影响因子: 6.38
索引于
  • 打开 J 门
  • Genamics 期刊搜索
  • 全球影响因子 (GIF)
  • 开放档案倡议
  • 中国知网(CNKI)
  • 研究期刊索引目录 (DRJI)
  • OCLC-WorldCat
  • 普罗奎斯特传票
  • 普布隆斯
  • 米亚尔
  • 大学教育资助委员会
  • 日内瓦医学教育与研究基金会
  • 谷歌学术
  • Scimago期刊排名
  • 秘密搜索引擎实验室
  • 研究之门
分享此页面

抽象的

Susceptibility of Beta-Haemolytic Escherichia coli to Commonly Used Antibiotics in Selected Hospitals in Delta State, Southern Nigeria

Itohan S Aghemwenhio, Adesoji A Timilehin and Alpheus GA

Antimicrobial resistance in the treatment of urinary tract infections is a major health problem. This study evaluates the pattern of susceptibility of pathogens commonly responsible for urinary tract infections (UTIs) to commonly used antimicrobial agents. Midstream urine samples of 80 patients (30 males and 50 females) and 20 diarrhea samples from 10 males and 10 females, who were attending clinics in Eku, Sapele and Abraka general hospitals, Delta state, between September and October 2007 were examined. Susceptibility of the urine and diarrhea bacteria isolates to ten commonly used antibiotics were investigated. Thirty five Escherichia coli isolates were obtained from the urine samples, out of which were nine hemolytic strains (25.7%), and 10 E. coli isolates from diarrhea, out of which was one strain (10%). All the hemolytic strains exhibited a significantly high resistance to septrin, sparfloxacin, amoxicillin, streptomycin, chloramphenicol but were either moderately or highly sensitive to the augmentin and gentamycin. I conclude that the incidence of hemolytic strains in urinary tract infection was higher than that observed from diarrhea because Escherichia coli strains that cause urinary tract infection typically produce hemolysins which is an important virulent factorin pathogenesis of infection, whereas those strains that are part of the gastro intestinal micro flora may not produce hemolysins and majority of the antimicrobial agents that are commonly used to treat UTIs caused by Escherichia coli in the hospitals are no longer effective due to hemolysin production. Therefore, the development and strict management of antimicrobial policy, and surveillance for resistant organisms should be given priority in Nigeria.